{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:48:37Z","timestamp":1777132117634,"version":"3.51.4"},"reference-count":156,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2025NSCQ-GPX0326"],"award-info":[{"award-number":["CSTB2025NSCQ-GPX0326"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-LZX0081"],"award-info":[{"award-number":["CSTB2024NSCQ-LZX0081"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ciencias e da Tecnologia","doi-asserted-by":"publisher","award":["002\/2023\/ALC"],"award-info":[{"award-number":["002\/2023\/ALC"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ciencias e da Tecnologia","doi-asserted-by":"publisher","award":["003\/2026\/ALC"],"award-info":[{"award-number":["003\/2026\/ALC"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.autrev.2026.104051","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:45:40Z","timestamp":1774770340000},"page":"104051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of myeloid-derived suppressor cells in Sj\u00f6gren's disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Liang","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuanyi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent Kam Wai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0005","first-page":"97","article-title":"Primary sj\u00f6gren\u2019s syndrome","volume":"379","author":"Mariette","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-206860","article-title":"Is primary Sj\u00f6gren\u2019s syndrome an orphan disease? A critical appraisal of prevalence studies in Europe","volume":"74","author":"Cornec","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003591","article-title":"Estimated prevalence, incidence and healthcare costs of Sj\u00f6gren\u2019s syndrome in France: a national claims-based study","volume":"10","author":"Seror","year":"2024","journal-title":"RMD Open"},{"issue":"8","key":"10.1016\/j.autrev.2026.104051_bb0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary Sj\u00f6gren syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104051_bb0025","series-title":"Autoimmunity: From Bench to Bedside","year":"2013"},{"issue":"6","key":"10.1016\/j.autrev.2026.104051_bb0030","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/rheumatology\/keh170","article-title":"Measurement of fatigue and discomfort in primary Sjogren\u2019s syndrome using a new questionnaire tool","volume":"43","author":"Bowman","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2026.104051_bb0035","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sjogren\u2019s syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren\u2019s syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-0044-1785675","article-title":"Pulmonary manifestations of Sj\u00f6gren\u2019s disease","volume":"45","author":"Byrne","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.autrev.2026.104051_bb0050","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00296-022-05242-w","article-title":"Renal involvement in Sj\u0151gren\u2019s syndrome: predictors and impact on patient outcomes","volume":"43","author":"Chatterjee","year":"2023","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.autrev.2026.104051_bb0055","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41584-025-01268-z","article-title":"2023 international Rome consensus for the nomenclature of Sj\u00f6gren disease","volume":"21","author":"Ramos-Casals","year":"2025","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104051_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063090","article-title":"Role of the innate immunity signaling pathway in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"22","author":"Shimizu","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.autrev.2026.104051_bb0065","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.11311","article-title":"Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sj\u00f6gren\u2019s syndrome","volume":"48","author":"Salomonsson","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s42003-022-03344-6","article-title":"Immunofibroblasts regulate LT\u03b13 expression in tertiary lymphoid structures in a pathway dependent on ICOS\/ICOSL interaction","volume":"5","author":"Nayar","year":"2022","journal-title":"Commun Biol"},{"issue":"27","key":"10.1016\/j.autrev.2026.104051_bb0075","doi-asserted-by":"crossref","first-page":"13490","DOI":"10.1073\/pnas.1905301116","article-title":"Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology","volume":"116","author":"Nayar","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41467-024-54686-0","article-title":"Molecular and spatial analysis of tertiary lymphoid structures in Sjogren\u2019s syndrome","volume":"16","author":"Nayar","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104051_bb0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2017.10.019","article-title":"Cytokines as therapeutic targets in primary Sj\u00f6gren syndrome","volume":"184","author":"Retamozo","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.autrev.2026.104051_bb0090","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1186\/ar3504","article-title":"Impact of interleukin-21 in the pathogenesis of primary Sj\u00f6gren\u2019s syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands","volume":"13","author":"Kang","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.autrev.2026.104051_bb0095","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren\u2019s syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0100","first-page":"754","article-title":"High prevalence of serum metabolic alterations in primary Sj\u00f6gren\u2019s syndrome: influence on clinical and immunological expression","volume":"34","author":"Ramos-Casals","year":"2007","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12016-025-09023-8","article-title":"Lipid metabolism: an emerging player in Sj\u00f6gren\u2019s syndrome","volume":"68","author":"Chang","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104051_bb0110","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/rheumatology\/kel349","article-title":"Traditional cardiovascular risk factors in primary Sjogren\u2019s syndrome--role of dyslipidaemia","volume":"45","author":"Gerli","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104051_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.879516","article-title":"Cardiovascular involvement in Sj\u00f6gren\u2019s syndrome","volume":"13","author":"Atzeni","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104051_bb0120","article-title":"Sjogren\u2019s disease and elevated cardiovascular risk: Mechanisms and Treatment","volume":"12","author":"Behbodikhah","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.autrev.2026.104051_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.865373","article-title":"Cardiovascular disease in primary Sj\u00f6gren\u2019s syndrome: raising clinicians\u2019 awareness","volume":"13","author":"Casian","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.exer.2009.03.020","article-title":"Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland","volume":"89","author":"Wu","year":"2009","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.autrev.2026.104051_bb0135","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.ajpath.2020.09.002","article-title":"High-fat diet-induced functional and pathologic changes in lacrimal gland","volume":"190","author":"He","year":"2020","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.autrev.2026.104051_bb0140","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ard.2025.05.004","volume":"84","author":"Bowman","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020310","article-title":"Myeloid-derived suppressor cells in solid tumors","volume":"11","author":"Ma","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.autrev.2026.104051_bb0160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104051_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250345","article-title":"Myeloid-derived suppressor cells in the therapy of autoimmune diseases","volume":"53","author":"Beki\u0107","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2026.104051_bb0170","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.18632\/oncotarget.28303","article-title":"Myeloid-derived suppressor cells: cancer, autoimmune diseases, and more","volume":"13","author":"Shibata","year":"2022","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0175","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/annrheumdis-2014-205508","article-title":"Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis","volume":"75","author":"Guo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104051_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5474828","article-title":"The expansion of myeloid-derived suppressor cells is associated with joint inflammation in rheumatic patients with arthritis","volume":"2018","author":"Zhu","year":"2018","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/art.43046","article-title":"FoxO1 deficiency in monocytic myeloid-derived suppressor cells exacerbates b cell dysfunction in systemic lupus erythematosus","volume":"77","author":"Tan","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"16","key":"10.1016\/j.autrev.2026.104051_bb0190","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1042\/CS20200799","article-title":"Myeloid-derived suppressor cells shift Th17\/Treg ratio and promote systemic lupus erythematosus progression through arginase-1\/miR-322-5p\/TGF-\u03b2 pathway","volume":"134","author":"Pang","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009742.2012.716450","article-title":"Increased circulating myeloid-derived suppressor cells correlated negatively with th17 cells in patients with rheumatoid arthritis","volume":"42","author":"Jiao","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104051_bb0200","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/art.39767","article-title":"Myeloid-derived suppressor cells induce the expansion of regulatory b cells and ameliorate autoimmunity in the sanroque mouse model of systemic lupus erythematosus","volume":"68","author":"Park","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104051_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119083","article-title":"The role of myeloid-derived suppressor cells in rheumatoid arthritis: an update","volume":"269","author":"Navashenaq","year":"2021","journal-title":"Life Sci"},{"issue":"10","key":"10.1016\/j.autrev.2026.104051_bb0210","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.humimm.2021.06.008","article-title":"Myeloid-derived suppressor cells: important communicators in systemic lupus erythematosus pathogenesis and its potential therapeutic significance","volume":"82","author":"Asgarzade","year":"2021","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0215","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/imm.13570","article-title":"Notch1 signalling controls the differentiation and function of myeloid-derived suppressor cells in systemic lupus erythematosus","volume":"168","author":"Li","year":"2023","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0220","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4049\/jimmunol.1203535","article-title":"Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis","volume":"191","author":"Fujii","year":"2013","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104051_bb0225","first-page":"2538","article-title":"The pathogenic role of metabolism in Sj\u00f6gren\u2019s syndrome","volume":"41","author":"Colafrancesco","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104051_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104668","article-title":"Cellular metabolic disorders in a cohort of patients with Sjogren\u2019s disease","volume":"26","author":"Ambrus","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.autrev.2026.104051_bb0235","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.autrev.2026.104051_bb0240","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3389\/fimmu.2019.01399","article-title":"Lipid metabolic pathways confer the immunosuppressive function of myeloid-derived suppressor cells in tumor","volume":"10","author":"Yan","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010250","article-title":"Fatty acid metabolism in myeloid-derived suppressor cells and tumor-associated macrophages: key factor in cancer immune evasion","volume":"14","author":"Siddiqui","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.autrev.2026.104051_bb0250","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","article-title":"Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"10.1016\/j.autrev.2026.104051_bb0255","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and t cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.autrev.2026.104051_bb0260","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","article-title":"T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants","volume":"186","author":"Hirschhorn","year":"2023","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0265","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","article-title":"Therapeutic targeting of tumour myeloid cells","volume":"23","author":"Barry","year":"2023","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0270","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ccell.2023.02.009","article-title":"Functional states of myeloid cells in cancer","volume":"41","author":"van Vlerken-Ysla","year":"2023","journal-title":"Cancer Cell"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2026.104051_bb0275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000489830","article-title":"Myeloid-derived suppressor cells in infection: a general overview","volume":"10","author":"Medina","year":"2018","journal-title":"J Innate Immun"},{"key":"10.1016\/j.autrev.2026.104051_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.975261","article-title":"Role of myeloid-derived suppressor cells in the formation of pre-metastatic niche","volume":"12","author":"Ya","year":"2022","journal-title":"Front Oncol"},{"issue":"1a","key":"10.1016\/j.autrev.2026.104051_bb0285","first-page":"7","article-title":"The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment","volume":"22","author":"Chouaib","year":"2018","journal-title":"Contemp Oncol (Pozn)"},{"key":"10.1016\/j.autrev.2026.104051_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1435306","article-title":"The role of hypoxic microenvironment in autoimmune diseases","volume":"15","author":"Gong","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104051_bb0295","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.2011.08678.x","article-title":"Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy","volume":"153","author":"Tadmor","year":"2011","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0300","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.18632\/oncotarget.12278","article-title":"On the origin of myeloid-derived suppressor cells","volume":"8","author":"Millrud","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0305","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104051_bb0310","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3389\/fimmu.2019.01099","article-title":"Myeloid-derived suppressor cells: not only in tumor immunity","volume":"10","author":"Pawelec","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0315","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-023-02627-y","article-title":"Aryl hydrocarbon receptor nuclear translocator limits the recruitment and function of regulatory neutrophils against colorectal cancer by regulating the gut microbiota","volume":"42","author":"Bi","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.autrev.2026.104051_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092626","article-title":"Targeting myeloid-derived suppressor cells in cancer immunotherapy","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041011","article-title":"Metabolic regulation of myeloid-derived suppressor cell function in cancer","volume":"9","author":"Wang","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0335","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2026.104051_bb0340","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.autrev.2026.104051_bb0345","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ijc.31744","article-title":"Myeloid-derived suppressor cells: roles in the tumor microenvironment and tumor radiotherapy","volume":"144","author":"Yin","year":"2019","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0350","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00262-015-1782-5","article-title":"Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study","volume":"65","author":"Mandruzzato","year":"2016","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0355","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40364-023-00475-8","article-title":"Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies","volume":"11","author":"Wang","year":"2023","journal-title":"Biomark Res"},{"issue":"5","key":"10.1016\/j.autrev.2026.104051_bb0360","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.autrev.2026.104051_bb0365","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1007\/s00018-021-03966-9","article-title":"Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases","volume":"78","author":"Ling","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10.1016\/j.autrev.2026.104051_bb0370","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/s41423-022-00943-5","article-title":"Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sj\u00f6gren\u2019s syndrome","volume":"19","author":"Wei","year":"2022","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0375","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41420-023-01507-w","article-title":"STAT3 and HIF1\u03b1 cooperatively mediate the transcriptional and physiological responses to hypoxia","volume":"9","author":"Dinarello","year":"2023","journal-title":"Cell Death Discov"},{"issue":"7","key":"10.1016\/j.autrev.2026.104051_bb0380","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/1541-7786.MCR-07-2177","article-title":"Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells","volume":"6","author":"Niu","year":"2008","journal-title":"Mol Cancer Res"},{"issue":"6","key":"10.1016\/j.autrev.2026.104051_bb0385","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41401-021-00776-4","article-title":"Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0390","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41416-019-0644-x","article-title":"Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells","volume":"122","author":"Hu","year":"2020","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.autrev.2026.104051_bb0395","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.20050715","article-title":"Arginase i in myeloid suppressor cells is induced by COX-2 in lung carcinoma","volume":"202","author":"Rodriguez","year":"2005","journal-title":"J Exp Med"},{"issue":"7\u20138","key":"10.1016\/j.autrev.2026.104051_bb0400","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.intimp.2009.03.021","article-title":"Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells","volume":"9","author":"Donkor","year":"2009","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"10.1016\/j.autrev.2026.104051_bb0405","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-12-4115","article-title":"Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms","volume":"73","author":"Mao","year":"2013","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0410","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0415","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates t-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.autrev.2026.104051_bb0420","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00262-020-02523-w","article-title":"Myeloid-derived suppressor cells impede t cell functionality and promote th17 differentiation in oral squamous cell carcinoma","volume":"69","author":"Dar","year":"2020","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0425","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.24700","article-title":"Myeloid suppressor cells induced by hepatitis c virus suppress t-cell responses through the production of reactive oxygen species","volume":"55","author":"Tacke","year":"2012","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.autrev.2026.104051_bb0430","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/ijc.28622","article-title":"Subpopulations of myeloid-derived suppressor cells impair t cell responses through independent nitric oxide-related pathways","volume":"134","author":"Raber","year":"2014","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.autrev.2026.104051_bb0435","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1084\/jem.20101956","article-title":"Chemokine nitration prevents intratumoral infiltration of antigen-specific t cells","volume":"208","author":"Molon","year":"2011","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0440","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00432-009-0634-0","article-title":"Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+\/CD14-\/CD15+\/CD33+ myeloid-derived suppressor cells and CD8+ t lymphocytes in patients with advanced-stage non-small cell lung cancer","volume":"136","author":"Liu","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104051_bb0445","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/rccm.201204-0636OC","article-title":"CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer","volume":"186","author":"Feng","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104051_bb0450","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated t cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"issue":"6\u20137","key":"10.1016\/j.autrev.2026.104051_bb0455","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/08820139.2012.673191","article-title":"Myeloid-derived suppressor cells and anti-tumor t cells: a complex relationship","volume":"41","author":"Monu","year":"2012","journal-title":"Immunol Invest"},{"issue":"8","key":"10.1016\/j.autrev.2026.104051_bb0460","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0465","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1158\/0008-5472.CAN-09-1882","article-title":"Immune stimulatory receptor CD40 is required for t-cell suppression and t regulatory cell activation mediated by myeloid-derived suppressor cells in cancer","volume":"70","author":"Pan","year":"2010","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.autrev.2026.104051_bb0470","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1158\/1078-0432.CCR-14-0635","article-title":"Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity","volume":"20","author":"Mao","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0475","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-\u03b1 blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.autrev.2026.104051_bb0480","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1172\/JCI64115","article-title":"TNF signaling drives myeloid-derived suppressor cell accumulation","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.autrev.2026.104051_bb0485","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00432-025-06315-6","article-title":"Advancing our understanding of the influence of myeloid-derived suppressor cells in chronic myeloid leukemia","volume":"151","author":"Meng","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104051_bb0490","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1002\/eji.201343349","article-title":"Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ t-cell activation events","volume":"43","author":"Schouppe","year":"2013","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0495","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4049\/jimmunol.0804253","article-title":"Myeloid-derived suppressor cells down-regulate l-selectin expression on CD4+ and CD8+ t cells","volume":"183","author":"Hanson","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.65","article-title":"Spontaneous model of Sj\u00f6gren\u2019s syndrome in NOD mice","volume":"86","author":"Scuron","year":"2019","journal-title":"Curr Protoc Pharmacol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0505","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s13287-020-01837-x","article-title":"Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2\/PGE2 in experimental sialadenitis","volume":"11","author":"Qi","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2026.104051_bb0510","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.molimm.2018.07.016","article-title":"Myeloid-derived suppressor cells exacerbate Sj\u00f6gren\u2019s syndrome by inhibiting th2 immune responses","volume":"101","author":"Qi","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2026.104051_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109073","article-title":"Targeting EZH2 prevents the occurrence and mitigates the development of Sj\u00f6gren\u2019s syndrome in mice","volume":"110","author":"Zhu","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0520","doi-asserted-by":"crossref","first-page":"E336","DOI":"10.1152\/ajpendo.00033.2023","article-title":"NOD mice have distinct metabolic and immunologic profiles when compared with genetically similar MHC-matched ICR mice","volume":"325","author":"Batdorf","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.autrev.2026.104051_bb0525","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/cmi.2017.8","article-title":"Proteasome inhibition suppresses th17 cell generation and ameliorates autoimmune development in experimental Sj\u00f6gren\u2019s syndrome","volume":"14","author":"Xiao","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104051_bb0530","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.4049\/jimmunol.1801051","article-title":"Increased GITRL impairs the function of myeloid-derived suppressor cells and exacerbates primary Sj\u00f6gren syndrome","volume":"202","author":"Tian","year":"2019","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0535","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41423-020-00587-3","article-title":"Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sj\u00f6gren\u2019s syndrome by modulating the function of myeloid-derived suppressor cells","volume":"18","author":"Rui","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0540","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41419-023-05631-4","article-title":"Fc\u03b3RIIIA activation-mediated up-regulation of glycolysis alters MDSCs modulation in CD4(+) t cell subsets of Sj\u00f6gren syndrome","volume":"14","author":"Qi","year":"2023","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0545","doi-asserted-by":"crossref","first-page":"053","DOI":"10.5606\/ArchRheumatol.2019.6813","article-title":"Distribution of myeloid-derived suppressor cells in rheumatoid arthritis and Sj\u00f6grens syndrome","volume":"34","author":"Ieva","year":"2019","journal-title":"Archives of Rheumatology"},{"key":"10.1016\/j.autrev.2026.104051_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104286","article-title":"Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy","volume":"362","author":"Adeshakin","year":"2021","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0555","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4078\/jrd.2022.29.3.140","article-title":"The mechanism of the NLRP3 inflammasome activation and pathogenic implication in the pathogenesis of gout","volume":"29","author":"Kim","year":"2022","journal-title":"J Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2026.104051_bb0560","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/intimm\/dxad037","article-title":"IL-27 regulates NLRP3 inflammasome activation of MDSCs in experimental Sj\u00f6gren\u2019s syndrome","volume":"35","author":"Xia","year":"2023","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0565","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.autrev.2014.10.011","article-title":"GITR+ regulatory t cells in the treatment of autoimmune diseases","volume":"14","author":"Petrillo","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0570","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10753-024-02092-5","article-title":"Dimethyloxallyl glycine preconditioning promotes the anti-inflammatory and anti-fibrotic effects of human umbilical cord mesenchymal stem cells on kidney damage in systemic lupus erythematosus related to TGF-\u03b2\/Smad signaling pathway","volume":"48","author":"Ning","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2026.104051_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.604607","article-title":"Mesenchymal stem cell enhances the function of MDSCs in experimental Sj\u00f6gren syndrome","volume":"11","author":"Tian","year":"2020","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.autrev.2026.104051_bb0580","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1039\/D0BM01562H","article-title":"3D encapsulation and inflammatory licensing of mesenchymal stromal cells alter the expression of common reference genes used in real-time RT-qPCR","volume":"8","author":"Gonzalez-Pujana","year":"2020","journal-title":"Biomater Sci"},{"issue":"5","key":"10.1016\/j.autrev.2026.104051_bb0585","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.immuni.2018.09.015","article-title":"Aryl hydrocarbon receptor signaling cell intrinsically inhibits intestinal group 2 innate lymphoid cell function","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0590","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.stem.2020.12.017","article-title":"Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption","volume":"28","author":"Mondala","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.autrev.2026.104051_bb0595","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/1535-7163.MCT-21-0984","article-title":"Discovery and characterization of a novel aryl hydrocarbon receptor inhibitor, IK-175, and its inhibitory activity on tumor immune suppression","volume":"21","author":"McGovern","year":"2022","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"10.1016\/j.autrev.2026.104051_bb0600","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/1535-7163.MCT-13-0378","article-title":"Embelin reduces colitis-associated tumorigenesis through limiting IL-6\/STAT3 signaling","volume":"13","author":"Dai","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0605","first-page":"1131","article-title":"Interleukin-12 exacerbates Sj\u00f6gren\u2019s syndrome through induction of myeloid-derived suppressor cells","volume":"20","author":"Qi","year":"2019","journal-title":"Mol Med Rep"},{"issue":"15","key":"10.1016\/j.autrev.2026.104051_bb0610","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.autrev.2026.104051_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102511","article-title":"Exosomes: effectual players in rheumatoid arthritis","volume":"19","author":"Tavasolian","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2026.104051_bb0620","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/onc.2016.229","article-title":"Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2019.151899","article-title":"Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders","volume":"225","author":"Chand Dakal","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2026.104051_bb0630","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.coi.2018.03.015","article-title":"Plasticity and biological diversity of myeloid derived suppressor cells","volume":"51","author":"Ben-Meir","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104051_bb0635","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00011-022-01660-5","article-title":"GITRL impairs the immunosuppressive function of MDSCs via PTEN-mediated signaling pathway in experimental Sj\u00f6gren syndrome","volume":"71","author":"Tian","year":"2022","journal-title":"Inflamm Res"},{"issue":"5","key":"10.1016\/j.autrev.2026.104051_bb0640","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s12026-023-09390-4","article-title":"Extracellular vesicle-encapsulated miR-10a-5p derived from MDSCs restrains germinal center b cells in experimental Sj\u00f6gren\u2019s syndrome","volume":"71","author":"Zhou","year":"2023","journal-title":"Immunol Res"},{"issue":"9","key":"10.1016\/j.autrev.2026.104051_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9093057","article-title":"Contributions of major cell populations to Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Witas","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0650","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.42683","article-title":"Multimodal single-cell sequencing of b cells in primary Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Arvidsson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104051_bb0655","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1468469","article-title":"Subpopulation dynamics of t and b lymphocytes in Sj\u00f6gren\u2019s syndrome: implications for disease activity and treatment","volume":"15","author":"Meng","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104051_bb0660","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molimm.2024.02.008","article-title":"Predicting the risk of interstitial lung disease in patients with primary Sj\u00f6gren\u2019s syndrome: novel nomogram and elevated th2 cells","volume":"168","author":"Wang","year":"2024","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2026.104051_bb0665","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaut.2017.11.003","article-title":"Th17 cells in primary Sj\u00f6gren\u2019s syndrome: pathogenicity and plasticity","volume":"87","author":"Verstappen","year":"2018","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0670","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10067-013-2476-z","article-title":"Clinical parameter and th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sj\u00f6gren\u2019s syndrome","volume":"33","author":"Fei","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0675","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2026.2625552","article-title":"JAK inhibitor tofacitinib alleviates secretory dysfunction and Th17\/Treg imbalance in a Sj\u00f6gren\u2019s disease murine model","volume":"58","author":"Lin","year":"2026","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0680","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-022-01103-x","article-title":"Artesunate suppresses th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog\u0308ren\u2019s syndrome","volume":"7","author":"Xiao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"10.1016\/j.autrev.2026.104051_bb0685","doi-asserted-by":"crossref","DOI":"10.3390\/cells12101359","article-title":"The role of regulatory t cells in the onset and progression of primary Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Blinova","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.autrev.2026.104051_bb0690","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrrheum.2012.58","article-title":"Follicular helper t cells in immunity and systemic autoimmunity","volume":"8","author":"Craft","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104051_bb0695","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/s41423-025-01346-y","article-title":"The STING\/type I interferon axis drives the interplay between marginal zone b cells and t follicular helper cells in Sj\u00f6gren\u2019s disease","volume":"22","author":"Chen","year":"2025","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0700","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3899\/jrheum.160313","article-title":"B cell depletion therapy normalizes circulating follicular th cells in primary Sj\u00f6gren syndrome","volume":"44","author":"Verstappen","year":"2017","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0705","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chest.2020.10.011","article-title":"Consensus guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren\u2019s","volume":"159","author":"Lee","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0710","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12890-022-01868-5","article-title":"Interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome","volume":"22","author":"Lin","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0715","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","article-title":"Clinical pulmonary involvement in primary Sjogren\u2019s syndrome: prevalence, quality of life and mortality \u2013 a retrospective study based on registry data","volume":"52","author":"Palm","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104051_bb0720","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fimmu.2019.01327","article-title":"Pulmonary manifestations of primary Sj\u00f6gren\u2019s syndrome: underlying immunological mechanisms, clinical presentation, and management","volume":"10","author":"Gupta","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0725","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","article-title":"Interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome","volume":"16","author":"Roca","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2026.104051_bb0730","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1183\/13993003.01826-2015","article-title":"Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis","volume":"48","author":"Fernandez","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2026.104051_bb0735","article-title":"B7H3-dependent myeloid-derived suppressor cell recruitment and activation in pulmonary fibrosis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104051_bb0740","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500312RR","article-title":"Characterizing the emergence of myeloid-derived suppressor cell subsets in a murine model of pulmonary fibrosis","volume":"39","author":"Vedder","year":"2025","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.autrev.2026.104051_bb0745","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/path.4956","article-title":"CCR2(+) monocytic myeloid-derived suppressor cells (M-MDSCs) inhibit collagen degradation and promote lung fibrosis by producing transforming growth factor-\u03b21","volume":"243","author":"Lebrun","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2026.104051_bb0750","article-title":"Myeloid-derived suppressor cells and pulmonary hypertension","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0755","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1165\/rcmb.2017-0214OC","article-title":"Myeloid-derived suppressor cells are necessary for development of pulmonary hypertension","volume":"58","author":"Bryant","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104051_bb0760","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cei\/uxac025","article-title":"MDSCs and t cells in solid tumors and non-Hodgkin lymphomas: an immunosuppressive speech","volume":"208","author":"Cioccarelli","year":"2022","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104051_bb0765","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00262-015-1765-6","article-title":"Myeloid-derived suppressor cells inhibit t cell proliferation in human extranodal NK\/T cell lymphoma: a novel prognostic indicator","volume":"64","author":"Zhang","year":"2015","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0770","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40164-023-00399-x","article-title":"Surface TREM2 on circulating M-MDSCs as a novel prognostic factor for adults with treatment-na\u00efve diffuse large b-cell lymphoma","volume":"12","author":"Wang","year":"2023","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104051_bb0775","article-title":"Fecal microbiota transplantation modulates myeloid-derived suppressor cells and attenuates renal fibrosis in a murine model","volume":"47","author":"Wang","year":"2025","journal-title":"Ren Fail"},{"key":"10.1016\/j.autrev.2026.104051_bb0780","article-title":"Corrigendum: myeloid-derived suppressor cells alleviate renal fibrosis progression via regulation of CCL5-CCR5 axis","volume":"12","author":"Qiu","year":"2021","journal-title":"Front Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:19:21Z","timestamp":1777130361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":156,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1568997226000650"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104051","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of myeloid-derived suppressor cells in Sj\u00f6gren's disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104051"}}